Clinical trials
Active, not recruiting Immunoglobulin Light-chain Amyloidosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Attralus, Inc. | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| City of Hope Medical Center | 1 |
| Columbia University | 1 |
| Emory University | 1 |
| European Myeloma Network B.V. | 1 |
| National Cancer Institute (NCI) | 1 |
| Nexcella Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoglobulin Light-chain Amyloidosis | 13 |
| Multiple Myeloma | 3 |
| Blast Crisis | 2 |
| Burkitt Lymphoma | 2 |
| Congenital Abnormalities | 2 |
| Hodgkin Disease | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Intraocular Lymphoma | 2 |
| Leukemia, Biphenotypic, Acute | 2 |
| Leukemia, Hairy Cell | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.